The performance of an orthosilicic acid-releasing silica gel fiber fleece in wound healing

Biomaterials

Volumn 34, Issue 30, 2013, Pages 7314-7327

  Grotheer, Vera ^a,b   Goergens, Maria ^b   Fuchs, Paul C ^b,c   Dunda, Sebastian ^b   Pallua, Norbert ^b   Windolf, Joachim ^a   Suschek, Christoph V ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

IL 1 ; IL 6; IL 8; Inflammation; NF kB; Silica

Indexed keywords

ANTI-INFLAMMATORIES; HUMAN SKIN FIBROBLAST; IL-6; IL-8; INFLAMMATION; INORGANIC MATERIALS; NF-KB; WOUND HEALING PROCESS;

CELL CULTURE; ENDOTHELIAL CELLS; FIBROBLASTS; SILICA; SILICA GEL; WOOL;

SPINNING (FIBERS);

COLLAGEN; SILICA GEL; SILICIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; MONOCYTE; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; WOUND CLOSURE;

IL-1Β; IL-6; IL-8; INFLAMMATION; NF-KB; SILICA;

ANIMALS; BIOCOMPATIBLE MATERIALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; COLLAGEN; CYTOKINES; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; KERATINOCYTES; MALE; NF-KAPPA B; ORGANOSILICON COMPOUNDS; SILICA GEL; SILICIC ACID; SPECTROPHOTOMETRY, ATOMIC; SWINE; SWINE, MINIATURE; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

CELLS; SILICA; WOOL;

SUS;

EID: 84880506971     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.06.012     Document Type: Article

References (57)

1. Bennett N.T., Schultz G.S. Growth factors and wound healing: part II. Role in normal and chronic wound healing. Am J Surg 1993, 166:74-81.
2. Nwomeh B.C., Yager D.R., Cohen I.K. Physiology of the chronic wound. Clin Plast Surg 1998, 25:341-356.
3. Schreml S., Szeimies R.M., Karrer S., Heinlin J., Landthaler M., Babilas P. The impact of the pH value on skin integrity and cutaneous wound healing. JEur Acad Dermatol 2010, 24:373-378.
4. Xue M., Le N.T., Jackson C.J. Targeting matrix metalloproteases to improve cutaneous wound healing. Expert Opin Ther Tar 2006, 10:143-155.
5. Kolluru G.K., Bir S.C., Kevil C.G. Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Int J Vasc Med 2012, 2012:918267.
6. Menke N.B., Ward K.R., Witten T.M., Bonchev D.G., Diegelmann R.F. Impaired wound healing. Clin Dermatol 2007, 25:19-25.
7. Barrientos S., Stojadinovic O., Golinko M.S., Brem H., Tomic-Canic M. Perspective article: growth factors and cytokines in wound healing. Wound Repair Regen 2008, 16:585-601.
8. Weinstein D.A., Kirsner R.S. Refractory ulcers: the role of tumor necrosis factor-α. JAm Acad Dermat 2010, 63:146-154.
9. Trengove N.J., Bielefeldt-Ohmann H., Stacey M.C. Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers. Wound Repair Regen 2000, 8:13-25.
10. Baker E.A., Leaper D.J. Proteinases, their inhibitors, and cytokine profiles in acute wound fluid. Wound Repair Regen 2000, 8:392-398.
11. Wallace H.J., Stacey M.C. Levels of tumor necrosis factor-alpha and soluble TNF receptors in chronic venous leg ulcers - correlations to healing status. JInvest Dermatol 1998, 110:292-296.
12. Tarnuzzer R.W., Schultz G.S. Biochemical analysis of acute and chronic wound environments. Wound Repair Regen 1996, 4:321-325.
13. Widgerow A.D. Nanocrystalline silver, gelatinases and the clinical implications. Burns 2010, 36:965-974.
14. Trengove N.J., Stacey M.C., Macauley S., Bennett N., Gibson J., Burslem F., et al. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen 1999, 7:442-452.
15. Ashcroft G.S., Jeong M.-J., Ashworth J.J., Hardman M., Jin W., Moutsopoulos N., et al. Tumor necrosis factor-alpha (TNF-α) is a therapeutic target for impaired cutaneous wound healing. Wound Repair Regen 2012, 20:38-49.
16. Dinarello C.A. Blocking interleukin-1β in acute and chronic autoinflammatory diseases. JInt Med 2011, 269:16-28.
17. Parks W.C. Matrix metalloproteinases in repair. Wound Repair Regen 1999, 7:423-432.
18. Wall S.J., Bevan D., Thomas D.W., Harding K.G., Edwards D.R., Murphy G. Differential expression of matrix metalloproteinases during impaired wound healing of the diabetes mouse. JInvest Dermatol 2002, 119:91-98.
19. Gabbiani G. The myofibroblast: a key cell for wound healing and fibrocontractive diseases. Prog Clin Biol Res 1981, 54:183-194.
20. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. JPathol 2003, 200:500-503.
21. Bishop S.M., Walker M., Rogers A.A., Chen W.Y. Importance of moisture balance at the wound-dressing interface. JWound Care 2003, 12:125-128.
22. Eisenbud D., Hunter H., Kessler L., Zulkowski K. Hydrogel wound dressings: where do we stand in 2003?. Ostomy Wound Manage 2003, 49:52-57.
23. Uzun M., Anand S.C., Shah T. The effect of wound dressings on the pH stability of fluids. JWound Care 2012, 21:88-90. 2-5.
24. Wilkinson L.J., White R.J., Chipman J.K. Silver and nanoparticles of silver in wound dressings: a review of efficacy and safety. JWound Care 2011, 20:543-549.
25. Loke W.-K., Lau S.-K., Yong L.L., Khor E., Sum C.K. Wound dressing with sustained anti-microbial capability. JBiomed Mat Res 2000, 53:8-17.
26. Eberlein T., Assadian O. Clinical use of polihexanide on acute and chronic wounds for antisepsis and decontamination. Skin Pharmacol Physiol 2010, 23(Suppl.):45-51.
27. Kursawe M., Glaubitt W., Thierauf A. Biodegradable silica fibers from sols. JSol-Gel Sci Technol 1998, 13:267-271.
28. Middelkoop E., van den Bogaerdt A.J., Lamme E.N., Hoekstra M.J., Brandsma K., Ulrich M.M. Porcine wound models for skin substitution and burn treatment. Biomaterials 2004, 25:1559-1567.
29. Suschek C.V., Bruch-Gerharz D., Kleinert H., Forstermann U., Kolb-Bachofen V. Ultraviolet A1 radiation induces nitric oxide synthase-2 expression in human skin endothelial cells in the absence of proinflammatory cytokines. JInvest Dermatol 2001, 117:1200-1205.
30. Suschek C.V., Krischel V., Bruch-Gerharz D., Berendji D., Krutmann J., Kröncke K.-D., et al. Nitric oxide fully protects against UVA-induced apoptosis in tight correlation with Bcl-2 up-regulation. JBiol Chem 1999, 274:6130-6137.
31. Krischel V., Bruch-Gerharz D., Suschek C., Kroncke K.D., Ruzicka T., Kolb-Bachofen V. Biphasic effect of exogenous nitric oxide on proliferation and differentiation in skin derived keratinocytes but not fibroblasts. JInvest Dermatol 1998, 111:286-291.
32. Snyder R.J. Treatment of nonhealing ulcers with allografts. Clin Dermatol 2005, 23:388-395.
33. Taylor J.E., Laity P.R., Hicks J., Wong S.S., Norris K., Khunkamchoo P., et al. Extent of iron pick-up in deforoxamine-coupled polyurethane materials for therapy of chronic wounds. Biomaterials 2005, 26:6024-6033.
34. Edwards J.V., Howley P., Cohen I.K. Invitro inhibition of human neutrophil elastase by oleic acid albumin formulations from derivatized cotton wound dressings. Int J Pharmaceut 2004, 284:1-12.
35. Schonfelder U., Abel M., Wiegand C., Klemm D., Elsner P., Hipler U.C. Influence of selected wound dressings on PMN elastase in chronic wound fluid and their antioxidative potential invitro. Biomaterials 2005, 26:6664-6673.
36. Crovetti G., Martinelli G., Issi M., Barone M., Guizzardi M., Campanati B., et al. Platelet gel for healing cutaneous chronic wounds. Transfus Apher Sci 2004, 30:145-151.
37. Walmsley S. Advances in wound management: executive summary 2002, Clinica reports, PJB Publications, Ltd, London.
38. Feldmeyer L., Werner S., French L.E., Beer H.-D. Interleukin-1, inflammasomes and the skin. Eur J Cell Biol 2010, 89:638-644.
39. Dinarello C.A. Proinflammatory cytokines. Chest 2000, 118:503-508.
40. Ghazizadeh M. Essential role of IL-6 signaling pathway in keloid pathogenesis. JNihon Med Sch 2007, 74:11-22.
41. Kishimoto T., Hirano T. Molecular regulation of B lymphocyte response. Ann Rev Immunol 1988, 6:485-512.
42. Sawamura D., Meng X., Ina S., Sato M., Tamai K., Hanada K., et al. Induction of keratinocyte proliferation and lymphocytic infiltration by invivo introduction of the IL-6 gene into keratinocytes and possibility of keratinocyte gene therapy for inflammatory skin diseases using IL-6 mutant genes. JImmunol 1998, 161:5633-5639.
43. Tuttolomondo A., La Placa S., Di Raimondo D., Bellia C., Caruso A., Lo Sasso B., et al. Adiponectin, resistin and IL-6 plasma levels in subjects with diabetic foot and possible correlations with clinical variables and cardiovascular co-morbidity. Cardiovasc Diabetol 2010, 9:50.
44. Rennekampff H.-O., Hansbrough J.F., Kiessig V., Doré C., Sticherling M., Schröder J.-M. Bioactive interleukin-8 is expressed in wounds and enhances wound healing. JSurg Res 2000, 93:41-54.
45. Iocono J.A., Colleran K.R., Remick D.G., Gillespie B.W., Ehrlich H.P., Garner W.L. Interleukin-8 levels and activity in delayed-healing human thermal wounds. Wound Repair Regen 2000, 8:216-225.
46. Simmonds R.E., Foxwell B.M. Signalling, inflammation and arthritis. Rheumatology 2008, 47:584-590.
47. Gupta S.C., Sundaram C., Reuter S., Aggarwal B.B. Inhibiting NF-κB activation by small molecules as a therapeutic strategy. BBA-Gene Regul Mech 2010, 1799:775-787.
48. Tomasek J.J., Gabbiani G., Hinz B., Chaponnier C., Brown R.A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002, 3:349-363.
49. Desmouliere A., Redard M., Darby I., Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995, 146:56-66.
50. Desmouliere A., Geinoz A., Gabbiani F., Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. JCell Biol 1993, 122:103-111.
51. Ronnov-Jessen L., Petersen O.W. Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab Invest 1993, 68:696-707.
52. Roberts A.B., Sporn M.B., Assoian R.K., Smith J.M., Roche N.S., Wakefield L.M., et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis invivo and stimulation of collagen formation invitro. Proc Natl Acad Sci U S A 1986, 83:4167-4171.
53. Almawi W.Y., Melemedjian O.K. Negative regulation of nuclear factor-kappaB activation and function by glucocorticoids. JMol Endocrin 2002, 28:69-78.
54. Richters C.D., Paauw N.J., Mayen I., van Bloois L., Metselaer J.M., Storm G., et al. Administration of prednisolone phosphate-liposomes reduces wound contraction in a rat partial-thickness wound model. Wound Repair Regen 2006, 14:602-607.
55. Oishi Y., Fu Z.W., Ohnuki Y., Kato H., Noguchi T. Molecular basis of the alteration in skin collagen metabolism in response to invivo dexamethasone treatment: effects on the synthesis of collagen type I and III, collagenase, and tissue inhibitors of metalloproteinases. Brit J Dermatol 2002, 147:859-868.
56. Monzon R.I., LaPres J.J., Hudson L.G. Regulation of involucrin gene expression by retinoic acid and glucocorticoids. Cell Growth Differ 1996, 7:1751-1759.
57. Ballard P.L. Glucocorticoids and differentiation. Glucocorticoid hormone action 1979, 493-515. Springer, New York. J.D. Baxter, G.G. Rousseau (Eds.).